BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND EZH2, ENX-1, 2146, ENSG00000106462, Q15910, MGC9169 AND Diagnosis
17 results:

  • 1. diagnosis- and Prognosis-Related Gene Alterations in
    Morishita S; Komatsu N
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629188
    [No Abstract]    [Full Text] [Related]  

  • 2. Genomic Profiling Reveals the Variant Landscape of Sporadic Parathyroid Adenomas in Chinese Population.
    Tao X; Xu T; Lin X; Xu S; Fan Y; Guo B; Deng X; Jiao Q; Chen L; Wei Z; Chen C; Yang W; Zhang Z; Yu X; Yue H
    J Clin Endocrinol Metab; 2023 Jun; 108(7):1768-1775. PubMed ID: 36611251
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Atypical chronic myeloid leukemia and myelodysplastic/myeloproliferative neoplasm, not otherwise specified: 2023 update on diagnosis, risk stratification, and management.
    Patnaik MM; Tefferi A
    Am J Hematol; 2023 Apr; 98(4):681-689. PubMed ID: 36601682
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Histological and immunohistochemical features and genetic alterations in the malignant progression of giant cell tumor of bone: a possible association with TP53 mutation and loss of H3K27 trimethylation.
    Ishihara S; Yamamoto H; Iwasaki T; Toda Y; Yamamoto T; Yoshimoto M; Ito Y; Susuki Y; Kawaguchi K; Kinoshita I; Yamada Y; Kohashi K; Fujiwara T; Setsu N; Endo M; Matsumoto Y; Kakuda Y; Nakashima Y; Oda Y
    Mod Pathol; 2022 May; 35(5):640-648. PubMed ID: 34785767
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Gender-related differences in the outcomes and genomic landscape of patients with myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes.
    Karantanos T; Gondek LP; Varadhan R; Moliterno AR; DeZern AE; Jones RJ; Jain T
    Br J Haematol; 2021 Jun; 193(6):1142-1150. PubMed ID: 34028801
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Analysis of nonleukemic cellular subcompartments reconstructs clonal evolution of acute myeloid leukemia and identifies therapy-resistant preleukemic clones.
    Saeed BR; Manta L; Raffel S; Pyl PT; Buss EC; Wang W; Eckstein V; Jauch A; Trumpp A; Huber W; Ho AD; Lutz C
    Int J Cancer; 2021 Jun; 148(11):2825-2838. PubMed ID: 33411954
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The hematopoietic stem cell marker VNN2 is associated with chemoresistance in pediatric B-cell precursor ALL.
    Bornhauser B; Cario G; Rinaldi A; Risch T; Rodriguez Martinez V; Schütte M; Warnatz HJ; Scheidegger N; Mirkowska P; Temperli M; Möller C; Schumich A; Dworzak M; Attarbaschi A; Brüggemann M; Ritgen M; Mejstrikova E; Hofmann A; Buldini B; Scarparo P; Basso G; Maglia O; Gaipa G; Skoblyn TL; Te Kronnie G; Vendramini E; Panzer-Grümayer R; Barz MJ; Marovca B; Hauri-Hohl M; Niggli F; Eckert C; Schrappe M; Stanulla M; Zimmermann M; Wollscheid B; Yaspo ML; Bourquin JP
    Blood Adv; 2020 Sep; 4(17):4052-4064. PubMed ID: 32853382
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Serous BMP8A has Clinical Significance in the Ultrasonic diagnosis of Thyroid cancer and Promotes Thyroid cancer Cell Progression.
    Liu K; Gao M; Qin D; Wang H; Lu Q
    Endocr Metab Immune Disord Drug Targets; 2020; 20(4):591-598. PubMed ID: 31656161
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan.
    Edahiro Y; Araki M; Inano T; Ito M; Morishita S; Misawa K; Fukuda Y; Imai M; Ohsaka A; Komatsu N
    Eur J Haematol; 2019 Jun; 102(6):516-520. PubMed ID: 30977935
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions.
    Schiano C; Soricelli A; De Nigris F; Napoli C
    Expert Rev Clin Immunol; 2019 Mar; 15(3):289-301. PubMed ID: 30570412
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet.
    Barbui T; Tefferi A; Vannucchi AM; Passamonti F; Silver RT; Hoffman R; Verstovsek S; Mesa R; Kiladjian JJ; Hehlmann R; Reiter A; Cervantes F; Harrison C; Mc Mullin MF; Hasselbalch HC; Koschmieder S; Marchetti M; Bacigalupo A; Finazzi G; Kroeger N; Griesshammer M; Birgegard G; Barosi G
    Leukemia; 2018 May; 32(5):1057-1069. PubMed ID: 29515238
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Presentation and outcome of patients with 2016 WHO diagnosis of prefibrotic and overt primary myelofibrosis.
    Guglielmelli P; Pacilli A; Rotunno G; Rumi E; Rosti V; Delaini F; Maffioli M; Fanelli T; Pancrazzi A; Pietra D; Salmoiraghi S; Mannarelli C; Franci A; Paoli C; Rambaldi A; Passamonti F; Barosi G; Barbui T; Cazzola M; Vannucchi AM;
    Blood; 2017 Jun; 129(24):3227-3236. PubMed ID: 28351937
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Update from the latest WHO classification of MPNs: a user's manual.
    Passamonti F; Maffioli M
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):534-542. PubMed ID: 27913526
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic impact of bone marrow fibrosis in primary myelofibrosis. A study of the AGIMM group on 490 patients.
    Guglielmelli P; Rotunno G; Pacilli A; Rumi E; Rosti V; Delaini F; Maffioli M; Fanelli T; Pancrazzi A; Pieri L; Fjerza R; Pietra D; Cilloni D; Sant'Antonio E; Salmoiraghi S; Passamonti F; Rambaldi A; Barosi G; Barbui T; Cazzola M; Vannucchi AM
    Am J Hematol; 2016 Sep; 91(9):918-22. PubMed ID: 27264006
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified.
    Wang SA; Tam W; Tsai AG; Arber DA; Hasserjian RP; Geyer JT; George TI; Czuchlewski DR; Foucar K; Rogers HJ; Hsi ED; Bryan Rea B; Bagg A; Dal Cin P; Zhao C; Kelley TW; Verstovsek S; Bueso-Ramos C; Orazi A
    Mod Pathol; 2016 Aug; 29(8):854-64. PubMed ID: 27174585
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Myeloproliferative neoplasms: molecular pathophysiology, essential clinical understanding, and treatment strategies.
    Tefferi A; Vainchenker W
    J Clin Oncol; 2011 Feb; 29(5):573-82. PubMed ID: 21220604
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. 5q- in a child with refractory anemia with excess blasts: similarities to 5q- syndrome in adults.
    Antillón F; Raimondi SC; Fairman J; Liang H; Nagarajan L; Head D; Ribeiro RC
    Cancer Genet Cytogenet; 1998 Sep; 105(2):119-22. PubMed ID: 9723027
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.